Helicobacter pylori-miRNA interaction in gastric cancer tissues: First prospective study from Turkey

Area of Science:

• Oncology
• Molecular Biology
• Genetics

Background:

• Helicobacter pylori (H. pylori) infection is a known risk factor in the development of gastric cancer (GC).
• MicroRNAs (miRNAs) are crucial regulators of gene expression, implicated in various stages of tumorigenesis, including cancer progression and metastasis.
• Understanding miRNA expression patterns in GC associated with H. pylori infection is vital for elucidating disease mechanisms.

Purpose of the Study:

• To investigate and compare miRNA expression profiles in gastric cancer tissues from patients with and without H. pylori infection.
• To identify specific miRNAs whose expression is significantly altered by H. pylori in the context of GC.

Main Methods:

• Microarray analysis was employed to screen miRNA expression profiles in 40 GC patients (20 H. pylori (+) and 20 H. pylori (-)) and a healthy control group.
• Quantitative RT-PCR was utilized to validate the expression levels of selected differentially expressed miRNAs.

Main Results:

• Microarray analysis identified 9 upregulated and 4 downregulated miRNAs.
• Quantitative RT-PCR confirmed significant upregulation of hsa-miR-194 (4.24-fold in tumor, 3.83-fold in non-tumor mucosa) and downregulation of hsa-miR-145 (0.33-fold in tumor, 0.43-fold in non-tumor mucosa) in H. pylori (+) GC patients compared to H. pylori (-) GC patients.
• H. pylori infection status was found to significantly influence the expression levels of hsa-miR-194 and hsa-miR-145.

Conclusions:

• H. pylori infection significantly modulates specific miRNA expression, including hsa-miR-194 and hsa-miR-145, in gastric cancer patients.
• These altered miRNA profiles may play a role in the pathogenesis of H. pylori-associated GC.
• Variations in H. pylori strain virulence could potentially contribute to observed differences in miRNA expression levels.